← back to search

Mark D. Kochenderfer

Carilion Roanoke Memorial Hospital · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, Colorectal Cancer Treatments and Studies, and Cancer Genomics and Diagnostics.
h-index
14
citations
2,280
works
26
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study
Journal of Clinical Oncology 2025cited by 33position: middledoi
A phase 1b multitumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors (COSMIC-021): Results of the colorectal cancer cohort.
Journal of Clinical Oncology 2022cited by 19position: middledoi
Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
Clinical Genitourinary Cancer 2020cited by 105position: middledoi
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
Clinical Colorectal Cancer 2016cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ian D. Schnadig · Nebraska Cancer Specialists2 papers (2016–2020)— · 1 papers (2020–2020)Vijay Gunuganti · Personalis (United States)1 papers (2020–2020)— · 1 papers (2020–2020)Nghia Nguyen · Université Laval1 papers (2016–2016)Rohit Jain · Gujarat Cancer Society1 papers (2020–2020)Robert Galamaga · Barrow Neurological Institute1 papers (2020–2020)— · 1 papers (2016–2016)— · 1 papers (2020–2020)Sanjay Goel · Montefiore Medical Center1 papers (2022–2022)Ignacio Garrido‐Laguna · University of Utah1 papers (2022–2022)Diana F. Hausman · University of Colorado Denver1 papers (2016–2016)Ralph J. Hauke · Nebraska Cancer Specialists1 papers (2020–2020)— · 1 papers (2016–2016)Todd M. Bauer · The University of Texas MD Anderson Cancer Center1 papers (2020–2020)M. Brent McHenry · Bristol-Myers Squibb (United States)1 papers (2020–2020)— · 1 papers (2020–2020)Vivek Subbiah · International Drug Development1 papers (2022–2022)Alexander I. Spira · Inova Fairfax Hospital1 papers (2016–2016)Thomas A. Abrams · Harvard University1 papers (2022–2022)